Tucatinib is a small molecule tyrosine kinase inhibitor approved by the U.S. Food and Drug Administration (FDA) for the treatment of metastatic HER2-positive breast cancer. It is used in combination with trastuzumab and capecitabine for the first-line treatment of adult patients with advanced or metastatic HER2-positive breast cancer. It works by blocking certain proteins that stimulate the growth of cancer cells. It is taken orally in capsule form.
Tucatinib is a medication used to treat specific types of cancer. Here's a breakdown of its key points:
Type of Drug: Tucatinib is a kinase inhibitor. This means it targets and blocks specific enzymes (kinases) involved in the growth and spread of cancer cells.
Cancer Types: Tucatinib is approved by the FDA for the treatment of two types of cancer:
- HER2-Positive Metastatic Breast Cancer: In adults with advanced or metastatic breast cancer where the cancer cells are HER2-positive. HER2 positivity indicates the presence of high levels of a protein called human epidermal growth factor receptor 2, which can promote cancer cell growth. Tucatinib is used in combination with two other medications, trastuzumab and capecitabine, for patients who haven't responded well to other HER2-targeted treatments.
- RAS Wild-Type, HER2-Positive Metastatic Colorectal Cancer: For adults with advanced or metastatic colorectal cancer that is both HER2-positive and RAS wild-type. RAS wild-type means specific genes (RAS) are not mutated, which can influence treatment options. Tucatinib is used with trastuzumab for patients whose cancer has progressed after treatment with other standard therapies.
How it Works: Tucatinib specifically targets the HER2 kinase, blocking its activity and interfering with the signals that tell cancer cells to grow and divide. This can help slow or stop tumor growth.
Dosage and Administration: Tucatinib is typically taken as a tablet by mouth twice daily. The exact dosage will depend on the specific condition being treated and other factors.
It's important to note that Tucatinib is always used in combination with other medications, not as a single therapy.
Here are some additional points to consider about Tucatinib:
- Side Effects: Like any medication, Tucatinib can cause side effects. Some common side effects include diarrhea, fatigue, nausea, vomiting, mouth sores, and dry skin. More serious side effects can also occur, so it's crucial to be aware of potential risks and discuss them with your doctor.
- Not for Everyone: Tucatinib is not suitable for everyone. Your doctor will consider your individual medical history and other conditions before recommending this medication.